Skip to main content
Caplight Logo









Unyte Health

Unyte Health

Private
United StatesHealthcare & Life Scienceshttps://integratedlistening.com/

Last Round

Grant

Oct 10, 2024

Total Funding Raised

$3.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Unyte Health is a neuro-tech company that provides a suite of evidence-based listening therapies and neural solutions designed to help regulate the nervous system for healthcare professionals and their clients.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

Safe and Sound ProtocolSSPauditory interventionnervous system regulationvagus nerve stimulationpolyvagal theorymultisensory therapymental health softwareclinical certificationtherapeutic toolsvertical SaaStrauma-informed caresensory processingdigital health platformneuro-based therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unyte Health Comparables

Compare Unyte Health with similar companies based on industry and business-model similarity.

Unyte Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Advanced Brain Technologies
80%
BrainTap
76%
Tomatis Developpement S.A.
76%

Unyte Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 10, 2024
Growth EquityMay 1, 2019

Unyte Health Investors

Notable investors and investment history

Unyte Health investors
InvestorRounds
Canadian Business Growth FundGrowth Equity
United States Department of DefenseGrant
Arc Capital DevelopmentVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Open roles increased to 31, 2.7x the trailing average.

  • Oct 10, 2024

    $3.8M grant from the United States Department of Defense.

Unyte Health Filings

Explore SEC and related filing metadata, where available.

Unyte Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Unyte Health's valuation, stock price, and market status.

Is Unyte Health a public or private company?

Unyte Health is a private company.

What is the current stock price of Unyte Health?

Unyte Health is a private company with no public stock price. No recent secondary market data is available.

How much is Unyte Health worth (valuation)?

Valuation information for Unyte Health is not publicly available.

Can I buy Unyte Health stock?

Unyte Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Unyte Health's last funding round?

Unyte Health's most recent funding round was Grant on October 10, 2024.

Who are the main investors in Unyte Health?

Key investors in Unyte Health include Canadian Business Growth Fund, United States Department of Defense.

Will Unyte Health IPO soon?

No public IPO plans have been announced for Unyte Health.

How can I track Unyte Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Unyte Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUnited States
Employee Range64
Year Founded2016
Last FundingOct 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?